| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/28/2005 | US20050090668 Via condensation of dihydroxyfumarate derivatives with amidines; chemical intermediates |
| 04/28/2005 | US20050090541 Indolinone derivatives and their use in treating disease-states such as cancer |
| 04/28/2005 | US20050090536 Substituted pyrrol-3-ylisoxazoles, e.g., N-benzyl-4-[4-(o-chlorophenyl)-5-isoxazolyl)pyrrole-2-carboxamide; treating diseases that are alleviated by a protein kinase inhibitor, particularly cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 04/28/2005 | US20050090534 5-carbonyl or carbamido-4-(4-chlorophenyl)-2-heteroaryl oxazoles; analgesic for diabetic neuropathy |
| 04/28/2005 | US20050090533 Treating schizophrenia by administering an N-(2-aminopyridin-5-yl)amino-phenylisobutyramide, e.g., N-[6-(2-acetylamino-ethylamino)-4-(2-chloro-phenyl)-pyridin-3-yl]-2-(3,5-bis-trifluoromethyl-phenyl)-N-methyl-isobutyramide |
| 04/28/2005 | US20050090515 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors |
| 04/28/2005 | US20050090504 Crohn's disease, ulcerative colitis, asthma, hypersensitivity pneumonitis, eosinophilic pneumonias, rhinitis, psoriasis, dermatitis and eczema |
| 04/28/2005 | US20050090501 Heteroaryl-cyclic acetals |
| 04/28/2005 | US20050090498 3-Quinolin-2(1h)-ylideneindolin-2-one derivative |
| 04/28/2005 | US20050090495 Receptor binding assay using radiolabeled interleukin inhibitors; antiinflammatory agents for eosinophil-dependent inflammatory diseases |
| 04/28/2005 | US20050090490 3-Substituted-4-pyrimidone derivatives |
| 04/28/2005 | US20050090485 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders |
| 04/28/2005 | US20050090398 Aryl ketone derivatives containing tetrazole moieties such as 5-cyclopropyl-4-{2,4-dichloro-3-[(1H-tetrazol-1-yl)methyl]benzoyl}isoxazole; good effect as a selective herbicide for paddy rice |
| 04/28/2005 | US20050089716 emits a light of a color with a high purity at a high luminance and has good durability |
| 04/28/2005 | US20050089713 Organic electroluminescent element |
| 04/28/2005 | CA2542723A1 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 04/28/2005 | CA2542653A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 04/28/2005 | CA2541509A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 04/28/2005 | CA2539767A1 1,3-benzoxazolyl derivatives as kinase inhibitors |
| 04/27/2005 | EP1526132A2 Substituted oxazolidinone derivatives and their use as factor xa inhibitors |
| 04/27/2005 | EP1525199A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 04/27/2005 | EP1524979A2 New effector conjugates, process for their production and their pharmaceutical use |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1423110A4 Cbi analogues of cc-1065 and the duocarmycins |
| 04/27/2005 | EP1261327B1 Adenosine receptor modulators |
| 04/27/2005 | EP0942733B1 Use of nk-1 receptor antagonists for treating cognitive disorders |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610679A Efficient process for the preparation of a factor XA inhibitor |
| 04/27/2005 | CN1610677A Halogenated nitrobutadienes for controlling animal pests |
| 04/27/2005 | CN1610675A Benzothiazole- and benzoxazole-4, 7-dione derivatives and their use as CDC25 phosphatase inhibitors |
| 04/27/2005 | CN1610674A Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 04/27/2005 | CN1610673A Method for producing pyrazole compound |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610670A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/27/2005 | CN1610666A Benzamidine derivative |
| 04/27/2005 | CN1610546A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 04/27/2005 | CN1198838C Antipicornaviral compounds, their prepn. and use |
| 04/27/2005 | CN1198803C Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor |
| 04/27/2005 | CN1198607C Composition for treating or preventing glomerulopathy |
| 04/26/2005 | US6885026 Organic element for electroluminescent devices |
| 04/26/2005 | US6884813 Microbiocides used to treat eye and skin infections |
| 04/26/2005 | US6884812 Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence |
| 04/26/2005 | US6884758 2,4-Diamino-1,3,5-triazines, their preparation, and their use as herbicides and plant growth regulators |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/21/2005 | WO2005035530A1 A novel crystalline form of linezolid |
| 04/21/2005 | WO2005035526A1 Bicyclic compounds and their therapeutic use |
| 04/21/2005 | WO2005035510A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 04/21/2005 | WO2005035508A2 Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 04/21/2005 | WO2005035507A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035495A2 Fibrinogen receptor antagonists and their use |
| 04/21/2005 | WO2005035492A1 3-SUBSTITUTED β-LACTAMYL VASOPRESSIN V1A ANTAGONISTS |
| 04/21/2005 | WO2005034955A1 Substituted quinolines as protein tyrosine kinase enzyme inhibitors |
| 04/21/2005 | WO2005034952A2 Isoxazole and isothiazole compounds useful in the treatment of inflammation |
| 04/21/2005 | WO2005034941A1 Indoles and azaindoles as antiviral agents |
| 04/21/2005 | WO2005034870A2 Amide compounds and ion channel ligands and uses thereof |
| 04/21/2005 | WO2005034857A2 Methods and compositions comprising diamines as new anti-tubercular therapeutics |
| 04/21/2005 | WO2005034848A2 Inhibitors of cathepsin s |
| 04/21/2005 | WO2005023807A3 4 - heterobicyclyamino - substituted quinazolines and analogues therof as capsaicin - antagonists |
| 04/21/2005 | WO2005016267A3 Oxazole compounds for the treatment of neurodegenerative disorders |
| 04/21/2005 | WO2005013907A3 Pyrrolo[1,2-b]pyridazine derivatives |
| 04/21/2005 | WO2005004801A3 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 04/21/2005 | WO2004026863A8 Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors |
| 04/21/2005 | US20050085667 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 04/21/2005 | US20050085635 Method of mycophenolate mofetil preparation |
| 04/21/2005 | US20050085549 Hetrocyclic aryl sulphonamides |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085531 Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |
| 04/21/2005 | US20050085508 Gastrointestinal disorders; antiemetic agents; irritable bowel disorders; antipruritic agents |
| 04/21/2005 | US20050085497 Anticholesterol agents; reducing blood serum lipids; anticancer agents; antiarthritic agents; antiinflammatory agents; antitumor agents; immunosuppressants; obesity; hypotensive agents |
| 04/21/2005 | US20050085467 Androgen receptor antagonists |
| 04/21/2005 | US20050085466 such as 1-[4-(2-oxo-4-trifluoromethyl-1,2-dihydroquinolin-6-ylmethyl)benzenesulfonyl]-piperidine-3-carboxylic acid ethyl ester; for treatment of acne, alopecia, and oily skin; kits |
| 04/21/2005 | US20050085458 Heterocyclic compounds possessing affinity at 5ht1-type receptors and use thereof in therapy |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/21/2005 | CA2542031A1 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 04/21/2005 | CA2541667A1 Substituted pyrazinone compounds for the treatment of inflammation |
| 04/21/2005 | CA2541582A1 Indoles and azaindoles as antiviral agents |
| 04/21/2005 | CA2535930A1 Inhibitors of cathepsin s |
| 04/20/2005 | EP1523335A2 Injectable depot formulation comprising crystals of iloperidone |
| 04/20/2005 | EP1443934B1 Benzotriazepines as gastrin and cholecystokinin receptor ligands |
| 04/20/2005 | EP1349847B1 Oxybenzamides derivatives as factor xa inhibitors |
| 04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 04/20/2005 | EP1144395B1 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 04/20/2005 | EP1143977B1 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 04/20/2005 | EP1140904B1 Farnesyl protein transferase inhibitors |
| 04/20/2005 | EP0984947B1 Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| 04/20/2005 | EP0766669B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 04/20/2005 | CN1608065A Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase and pharmaceutical compositions containing the compounds |
| 04/20/2005 | CN1608061A Therapeutic isoquinoline compounds |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/20/2005 | CN1608053A Heterocyclic derivatives of glycinamide and its pharmaceutical uses |
| 04/20/2005 | CN1197862C 2-(3, 5-disubstituted-4-pyridyl)-4-arylphenyl-1, 3-oxazoline compounds |
| 04/19/2005 | US6881753 Potassium channel inhibitors and method |
| 04/19/2005 | US6881736 Inhibit the vitronectin receptor and are useful for the treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor, such as |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |